Johnson Matthey PLC (OTCMKTS:JMPLY – Get Free Report)’s share price fell 1.6% on Tuesday . The stock traded as low as $55.03 and last traded at $55.2450. 539 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 3,226 shares. The stock had previously closed at $56.1350.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on JMPLY. Zacks Research raised shares of Johnson Matthey from a “hold” rating to a “strong-buy” rating in a report on Wednesday, October 8th. Citigroup reaffirmed a “neutral” rating on shares of Johnson Matthey in a report on Tuesday, October 21st. Finally, Jefferies Financial Group raised shares of Johnson Matthey to a “strong-buy” rating in a report on Thursday, October 9th. Two equities research analysts have rated the stock with a Strong Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy”.
Get Our Latest Report on JMPLY
Johnson Matthey Trading Down 1.6%
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Insider Trading – What You Need to Know
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- How to Invest in Biotech Stocks
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- What is the Euro STOXX 50 Index?
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
